Erenumab in highly therapy-refractory migraine patients: First German real-world evidence
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1129-2377
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Erenumab in highly therapy-refractory migraine patients: First German real-world evidence ; volume:21 ; number:1 ; day:3 ; month:7 ; year:2020 ; pages:1-5 ; date:12.2020
The journal of headache and pain ; 21, Heft 1 (3.7.2020), 1-5, 12.2020
- Creator
-
Scheffler, Armin
Messel, Olga
Wurthmann, Sebastian
Nsaka, Michael
Kleinschnitz, Christoph
Glas, Martin
Naegel, Steffen
Holle, Dagny
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s10194-020-01151-0
- URN
-
urn:nbn:de:101:1-2020083119175561194493
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:03 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Scheffler, Armin
- Messel, Olga
- Wurthmann, Sebastian
- Nsaka, Michael
- Kleinschnitz, Christoph
- Glas, Martin
- Naegel, Steffen
- Holle, Dagny
- SpringerLink (Online service)
Other Objects (12)
A prospective real-world analysis of erenumab in refractory chronic migraine
Combined Interventional Treatment of Refractory Chronic Migraine
Refractory migraine in a headache clinic population
Identifying and managing refractory migraine: barriers and opportunities?
First-year real-world experience of intravitreal brolucizumab injection for refractory neovascular age-related macular degeneration
Preventive effect of cyproheptadine hydrochloride in refractory patients with frequent migraine
First real-world study on the effectiveness and tolerability of rimegepant for acute migraine therapy in Chinese patients
Infliximab therapy in refractory sarcoidosis: a multicenter real-world analysis
Intravenous ketamine for subacute treatment of refractory chronic migraine: a case series
Gleaning after the European Headache Federation consensus statement on refractory chronic migraine
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study
Migraine treatment: quo vadis? Real-world data study (2015–2022) in Spain
A prospective real-world analysis of erenumab in refractory chronic migraine
Combined Interventional Treatment of Refractory Chronic Migraine
Refractory migraine in a headache clinic population
Identifying and managing refractory migraine: barriers and opportunities?
First-year real-world experience of intravitreal brolucizumab injection for refractory neovascular age-related macular degeneration
Preventive effect of cyproheptadine hydrochloride in refractory patients with frequent migraine
First real-world study on the effectiveness and tolerability of rimegepant for acute migraine therapy in Chinese patients
Infliximab therapy in refractory sarcoidosis: a multicenter real-world analysis
Intravenous ketamine for subacute treatment of refractory chronic migraine: a case series
Gleaning after the European Headache Federation consensus statement on refractory chronic migraine
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study
Migraine treatment: quo vadis? Real-world data study (2015–2022) in Spain
A prospective real-world analysis of erenumab in refractory chronic migraine
Combined Interventional Treatment of Refractory Chronic Migraine
Refractory migraine in a headache clinic population
Identifying and managing refractory migraine: barriers and opportunities?
First-year real-world experience of intravitreal brolucizumab injection for refractory neovascular age-related macular degeneration
Preventive effect of cyproheptadine hydrochloride in refractory patients with frequent migraine
First real-world study on the effectiveness and tolerability of rimegepant for acute migraine therapy in Chinese patients
Infliximab therapy in refractory sarcoidosis: a multicenter real-world analysis
Intravenous ketamine for subacute treatment of refractory chronic migraine: a case series
Gleaning after the European Headache Federation consensus statement on refractory chronic migraine
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study